Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   VETERINARY RESEARCH FORUM   2012 , Volume 3 , Number 2; Page(s) 91 To 95.
 
Paper: 

EFFECT OF PILOCARPINE ON THE FORMALIN-INDUCED OROFACIAL PAIN IN RATS

 
 
Author(s):  TAMADDONFARD ESMAEAL*, ERFANPARAST AMIR, KHALILZADEH EMAD
 
* DIVISION OF PHYSIOLOGY, DEPARTMENT OF BASIC SCIENCES, FACULTY OF VETERINARY MEDICINE, URMIA UNIVERSITY, URMIA, IRAN
 
Abstract: 

In this study, the effects of subcutaneous (SC) injection of pilocarpine (a cholinomimetic agent) and atropine (a muscarinic receptors antagonist) were investigated on a tonic model of orofacial pain in rats. The contribution of the endogenous analgesic opioid system was assessed using naloxone (an opioid receptors antagonist). Tonic orofacial pain was induced by SC injection of a diluted formalin solution (1%, 50mL) in the right upper lip, and the time spent face rubbing was measured in five min blocks for 1 h. Formalin induced a biphasic (first phase: 0-5 min and second phase: 15-35 min) pain response. Pilocarpine significantly (P<0.05) suppressed both phases of orofacial pain. Atropine did not have any effect and naloxone non-significantly increased the intensity of pain when used alone. In the pre-injection examinations, atropine prevented, but naloxone did not reverse the antinociceptive effect of pilocarpine. The results indicated that SC injection of formalin in the orofacial region induced a marked biphasic pain. Pilocarpine via muscarinic cholinergic receptors produced antinociceptive effect in the orofacial formalin-induced pain. The endogenous opioid analgesic system may not have a role in pilocarpine-induced antinociception.

 
Keyword(s): PILOCARPINE, ATROPINE, NALOXONE, OROFACIAL PAIN, RAT
 
References: 
  • ندارد
 
  pdf-File tarjomyar Yearly Visit 61
 
Latest on Blog
Enter SID Blog